- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Article
Tacrolimus ointment not associated with skin cancer risk
Theory on cutaneous immune responses led to long-term safety trials and reassuring answer
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Shifting the Paradigm in Infant Atopic Dermatitis Treatment With Roflumilast
Investigating Roflumilast 0.05% Cream for Infant AD with Mercedes E. Gonzalez, MD
Clarifying Allergy Controversies in Pediatric Atopic Dermatitis
Heather Gates, PA-C, Leads Inaugural Aesthetics Workshop at Fall Clinical PA/NP
Julia Zimmermann PD, PhD, Demonstrates PHLAS, A New Cold Plasma Skin Care Device
What Dermatologists Need to Know About the Future of Regenerative Aesthetics
Redefining Anti-Aging with Regenerative Aesthetics and Growth Factor Skincare
Bridging the Communication Gap Between Providers and Patients Through the Skin Quality Index
Allergan Aesthetics' Effort to Create a Unified Vocabulary for Skin Quality
Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters
Related Content
